Chander Mohan
Geriatric Psychiatry · Shelby, OHNPI 1912943267
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,682 of the $1,897 with a category attached, or 88.7%. It is spread thinly across 14 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,093 and has fallen 97.9% since, to $23 in 2025.
Across 100 payments — averaging $18.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$411
- AbbVie$387
- Alkermes, Inc.$264
- Otsuka America Pharmaceutical, Inc.$199
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$192
- Lundbeck LLC$122
- plus $321 from 8 others
What the payments were for
- Food & beverage$1,68289%
- Education$21511%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $411 |
| AbbVie(2 entities) | 29 | $387 |
| Alkermes, Inc. | 13 | $264 |
| Otsuka America Pharmaceutical, Inc. | 13 | $199 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $192 |
| Lundbeck LLC | 7 | $122 |
| Neurocrine Biosciences, Inc. | 5 | $90 |
| Johnson & Johnson | 3 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Harmony Biosciences LLC | 1 | $41 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Noven Therapeutics, LLC | 1 | $15 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUSTEDO$125
How this compares
Too few geriatric psychiatry providers in Ohioto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 13 | $110,642 |
| Paliperidone ErPaliperidone | 32 | $6,799 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 24 | $2,640 |
| Lorazepam | 247 | $1,572 |
| Aripiprazole | 32 | $1,420 |
| Duloxetine Hcl | 127 | $1,348 |
| Trazodone Hcl | 127 | $1,105 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 21 | $1,002 |
| Clozapine | 15 | $995 |
| Benztropine Mesylate | 67 | $924 |
| LoxapineLoxapine Succinate | 11 | $862 |
| Escitalopram Oxalate | 137 | $806 |
| Quetiapine Fumarate | 105 | $789 |
| Mirtazapine | 43 | $640 |
| Alprazolam | 147 | $627 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $90 | $110,64213 claims |
| Teva Pharmaceuticals USA, Inc.Loxapine | $411 | $86211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few geriatric psychiatry providers in Ohioon file to place this against a meaningful peer group, so we don't.
Other geriatric psychiatry in Shelby
- Babu GuptaCincinnati$11K
- Brian ApplebyCleveland$6K
- Kasia RothenbergCleveland$6K
- Alfredo RiveraCincinnati$2K
- Rebecca SchlachetEuclid$496
- Philipp DinesCleveland$462
- Louis KleinRocky River$280
- Upma DhingraEuclid$277
- Robert SegravesBeachwood$251
- Ravinder MannCincinnati$202
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.